Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5–11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022
Supporting Files
-
7 14 2023
-
File Language:
English
Details
-
Alternative Title:J Infect Dis
-
Personal Author:Cortese, Margaret M. ; Taylor, Allan W. ; Akinbami, Lara J. ; Thames-Allen, Andrea ; Yousaf, Anna R. ; Campbell, Angela P. ; Maloney, Susan A. ; Harrington, Theresa A. ; Gloria Anyalechi, E. ; Munshi, Datta ; Kamidani, Satoshi ; Robinette Curtis, C. ; McCormick, David W. ; Staat, Mary A. ; Edwards, Kathryn M. ; Buddy Creech, C. ; Museru, Oidda ; Marquez, Paige ; Thompson, Deborah ; Su, John R. ; Schlaudecker, Elizabeth P. ; Broder, Karen R.
-
Description:Multisystem inflammatory syndrome in children (MIS-C) is a complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; in the United States, reporting of MIS-C after coronavirus disease 2019 (COVID-19) vaccination is required for vaccine safety monitoring. Pfizer-BioNTech COVID-19 vaccine was authorized for children aged 5-11 years on 29 October 2021. Covering a period when approximately 7 million children received vaccine, surveillance for MIS-C ≤ 90 days postvaccination using passive systems identified 58 children with MIS-C and laboratory evidence of past/recent SARS-CoV-2 infection, and 4 without evidence. During a period with extensive SARS-CoV-2 circulation, MIS-C illness in children after COVID-19 vaccination who lacked evidence of SARS-CoV-2 infection was rare (<1 per million vaccinated children).
-
Keywords:
-
Source:J Infect Dis. 228(2):143-148
-
Pubmed ID:36821777
-
Pubmed Central ID:PMC10563003
-
Document Type:
-
Funding:
-
Volume:228
-
Issue:2
-
Collection(s):
-
Main Document Checksum:urn:sha256:93c5131d6505623613f766cd0c544bff2246aac0368cc5b15b8d71424a5499ca
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access